| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2024 , Vol 62 , Num 4
The effect of a combination therapy of spironolactone and metformin on women with polycystic ovary syndrome
1 University of Baghdad, Faculty of Medicine, Department of Physiology, Baghdad, Iraq, 2 Al-Mustafa University College, Faculty of Medicine, Department of Radiology, Baghdad, Iraq, 3 Al-Kunooze University College, Faculty of Pharmacy, Basra, Iraq
DOI :
10.23893/1307-2080.APS6249